<?xml version="1.0" encoding="UTF-8"?>
<p>The penetration of the BBB for drug delivery, although challenging, captivates the interest of numerous researchers in antiviral therapy since the mechanisms by which for example HSV-1 penetrates the CNS remain unclear. The most likely routes include retrograde transport via the olfactory or trigeminal nerve fibres, occasionally leading to herpes simplex encephalitis (HSE) caused by HSV-1 [
 <xref rid="B108-pharmaceutics-12-00171" ref-type="bibr">108</xref>].
</p>
